SI
CRL icon

Shaker Investments’s Charles River Laboratories CRL Stock Holding History

Shaker Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,791
Closed -$1.4M – 95
2024
Q2 		$1.4M Sell
6,791
-25
-0.4% -$5.67K 0.61% 54
2024
Q1 		$1.85M Buy
6,816
+33
+0.5% +$7.88K 0.78% 51
2023
Q4 		$1.6M Sell
6,783
-1,119
-14% -$220K 0.75% 51
2023
Q3 		$1.55M Sell
7,902
-46
-0.6% -$9.44K 0.85% 45
2023
Q2 		$1.67M Sell
7,948
-2,014
-20% -$401K 0.85% 44
2023
Q1 		$2.01M Buy
9,962
+96
+1% +$21.8K 1.12% 31
2022
Q4 		$2.15M Buy
9,866
+7,534
+323% +$1.65M 1.33% 27
2022
Q3 		$459K Buy
2,332
+8
+0.3% +$1.73K 0.31% 68
2022
Q2 		$497K Buy
2,324
+3
+0.1% +$733 0.32% 75
2022
Q1 		$659K Sell
2,321
-1,833
-44% -$565K 0.34% 72
2021
Q4 		$1.56M Sell
4,154
-946
-19% -$368K 0.67% 41
2021
Q3 		$2.1M Buy
5,100
+33
+0.7% +$13.7K 0.93% 33
2021
Q2 		$1.87M Buy
5,067
+7
+0.1% +$2.34K 0.87% 37
2021
Q1 		$1.47M Sell
5,060
-435
-8% -$121K 0.71% 48
2020
Q4 		$1.37M Buy
5,495
+65
+1% +$15.5K 0.69% 46
2020
Q3 		$1.23M Hold
5,430
– – 0.63% 51
2020
Q2 		$947K Hold
5,430
– – 0.54% 46
2020
Q1 		$685K Buy
5,430
+195
+4% +$29.2K 0.59% 44
2019
Q4 		$800K Hold
5,235
– – 0.48% 51
2019
Q3 		$693K Hold
5,235
– – 0.45% 54
2019
Q2 		$743K Buy
5,235
+35
+0.7% +$4.75K 0.49% 49
2019
Q1 		$755K Hold
5,200
– – 0.52% 49
2018
Q4 		$588K Hold
5,200
– – 0.51% 43
2018
Q3 		$700K Hold
5,200
– – 0.43% 49
2018
Q2 		$584K Sell
5,200
-2,840
-35% -$307K 0.36% 55
2018
Q1 		$858K Hold
8,040
– – 0.53% 46
2017
Q4 		$880K Hold
8,040
– – 0.58% 39
2017
Q3 		$868K Buy
8,040
+1,640
+26% +$168K 0.6% 41
2017
Q2 		$647K Buy
+6,400
New +$589K 0.49% 50

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Shaker Investments's CRL Position: Q3 2024 in Review

Shaker Investments sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 6,791 shares — an estimated $1.4M sold.

Shaker Investments first reported a position in CRL in Q2 2017 and held it in 29 quarters. The position peaked at $2.15M in Q4 2022. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Shaker Investments reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • Shaker Investments sold 6,791 Charles River Laboratories shares in Q3 2024, an estimated $1.4M.
  • Shaker Investments first reported a position in Charles River Laboratories in Q2 2017 and held it in 29 quarters.
  • Shaker Investments's Charles River Laboratories position peaked at $2.15M in Q4 2022.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Shaker Investments's 13F filing for Q3 2024, filed 10 Oct 2024.